lncrna KcnQ1OT1 enhances the chemoresistance of oxaliplatin in colon cancer by targeting the mir-34a/aTg4B pathway

Purpose: The chemoresistance of colon cancer to oxaliplatin (L-OHP) indicates poor prognosis. Long non-coding RNA (lncRNA) KCNQ1OT1 (KCNQ1 opposite strand/antisense transcript 1) has been shown to participate in the tumorigenesis of several types of cancers. However, little is known about the role of KCNQ1OT1 in the chemoresistance and prognosis of colon cancer. Materials and methods: Quantitative-PCR and Western blot were used to measure the expression profiles of KCNQ1OT1, miR-34a, and Atg4B in colon cancer tissues and cells. Cell viability assay and flow cytometry were used to examine their effects on cell proliferation and death. Cleavage of LC3 and GFP-LC3 plasmid transfection were used to detect autophagic activity. Double luciferase reporter assay was used to verify the interactions between miRNA and lncRNA or mRNA. Xenograft tumor model was used to verify the effects of KCNQ1OT1 in vivo. Results: In this study, it is shown that the expression level of KCNQ1OT1 was increased in tumor, which indicated poor prognosis in colon cancer patients. Using colon cancer cell lines HCT116 and SW480, it was demonstrated that knockdown of KCNQ1OT1 decreased the cell viability and increased the apoptosis rates upon L-OHP treatment. Further studies indicated that Atg4B upregulation was partially responsible for KCNQ1OT1-induced protective autophagy and chemoresistance. Moreover, miR-34a functioned as a bridge between KCNQ1OT1 and Atg4B, which could be sponged by KCNQ1OT1, while it could also bind to the 3 ′ -UTR of Atg4B and downregulate its expressions. Finally, we show that the KCNQ1OT1/miR-34a/Atg4B axis regulated the chemoresistance of colon cancer cells in vitro and in vivo. Conclusion: lncRNA KCNQ1OT1 promoted the chemoresistance of colon cancer by sponging miR-34a, thus upregulating the expressions of Atg4B and enhancing protective autophagy. KCNQ1OT1 might become a promising target for colon cancer therapeutics.

[1]  Xiao-bin Cui,et al.  miR-34a Regulates Multidrug Resistance via Positively Modulating OAZ2 Signaling in Colon Cancer Cells , 2018, Journal of immunology research.

[2]  D. Klionsky,et al.  PINK1 and PARK2 Suppress Pancreatic Tumorigenesis through Control of Mitochondrial Iron-Mediated Immunometabolism. , 2018, Developmental cell.

[3]  A. Rafiee,et al.  Long noncoding RNAs: regulation, function and cancer , 2018, Biotechnology & genetic engineering reviews.

[4]  Daming Zhang,et al.  LncRNA KCNQ1OT1 regulates proliferation and cisplatin resistance in tongue cancer via miR-211-5p mediated Ezrin/Fak/Src signaling , 2018, Cell Death & Disease.

[5]  Jingyao Zhang,et al.  Long non-coding RNA KCNQ1OT1 mediates the growth of hepatocellular carcinoma by functioning as a competing endogenous RNA of miR-504. , 2018, International journal of oncology.

[6]  Ning Zhang,et al.  Role of microRNAs in the resistance of colorectal cancer to chemoradiotherapy. , 2018, Molecular and clinical oncology.

[7]  B. Li,et al.  AKT-mediated phosphorylation of ATG4B impairs mitochondrial activity and enhances the Warburg effect in hepatocellular carcinoma cells , 2018, Autophagy.

[8]  A. Scorilas,et al.  miR-34a overexpression predicts poor prognostic outcome in colorectal adenocarcinoma, independently of clinicopathological factors with established prognostic value. , 2017, Clinical biochemistry.

[9]  Aamir Ahmad,et al.  MicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different Cancers , 2017, International journal of molecular sciences.

[10]  Yongchao Li,et al.  TUG1 mediates methotrexate resistance in colorectal cancer via miR-186/CPEB2 axis. , 2017, Biochemical and biophysical research communications.

[11]  Yuehua Jiang,et al.  Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis , 2017, Oncotarget.

[12]  Jun-gang Zhao,et al.  Knockdown of long non-coding RNA KCNQ1OT1 depressed chemoresistance to paclitaxel in lung adenocarcinoma , 2017, Cancer Chemotherapy and Pharmacology.

[13]  A. Brenner,et al.  Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors , 2017, Investigational New Drugs.

[14]  S. Leung,et al.  Identification of breast cancer cell subtypes sensitive to ATG4B inhibition , 2016, Oncotarget.

[15]  T. Guo,et al.  SLC27A4 regulate ATG4B activity and control reactions to chemotherapeutics-induced autophagy in human lung cancer cells , 2016, Tumor Biology.

[16]  F. He,et al.  Targeting the MIR34C-5p-ATG4B-autophagy axis enhances the sensitivity of cervical cancer cells to pirarubicin , 2016, Autophagy.

[17]  M. Dinger,et al.  Endogenous microRNA sponges: evidence and controversy , 2016, Nature Reviews Genetics.

[18]  A. Sahebkar,et al.  MicroRNA-34a and its target genes: Key factors in cancer multidrug resistance. , 2016, Current pharmaceutical design.

[19]  Howard Y. Chang,et al.  Unique features of long non-coding RNA biogenesis and function , 2015, Nature Reviews Genetics.

[20]  Panayiotis Tsanakas,et al.  DIANA-LncBase v2: indexing microRNA targets on non-coding transcripts , 2015, Nucleic Acids Res..

[21]  F. Ren,et al.  Prognostic significance of MiR-34a in solid tumors: a systemic review and meta-analysis with 4030 patients. , 2015, International journal of clinical and experimental medicine.

[22]  Feng Ye,et al.  The predictive effect of overexpressed miR-34a on good survival of cancer patients: a systematic review and meta-analysis , 2015, OncoTargets and therapy.

[23]  John Calvin Reed,et al.  ATG4B (Autophagin-1) Phosphorylation Modulates Autophagy* , 2015, The Journal of Biological Chemistry.

[24]  A. Chaudhary,et al.  Targeting autophagy to overcome drug resistance in cancer therapy. , 2015, Future medicinal chemistry.

[25]  M. Esteller,et al.  Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance , 2015, Molecular Cancer Therapeutics.

[26]  E. Bowman,et al.  Increased MicroRNA-34b and -34c Predominantly Expressed in Stromal Tissues Is Associated with Poor Prognosis in Human Colon Cancer , 2015, PloS one.

[27]  Zhenglei Xu,et al.  miR-34a inhibits migration and invasion by regulating the SIRT1/p53 pathway in human SW480 cells , 2015, Molecular medicine reports.

[28]  Jun Yu,et al.  miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer , 2014, Oncogene.

[29]  P. Tassone,et al.  Mir-34: A New Weapon Against Cancer? , 2014, Molecular therapy. Nucleic acids.

[30]  X J Li,et al.  MicroRNA-34a: a potential therapeutic target in human cancer , 2014, Cell Death and Disease.

[31]  R. Knight,et al.  miR-34: from bench to bedside , 2014, Oncotarget.

[32]  Chaochun Liu,et al.  The imprinted H19 lncRNA antagonizes let-7 microRNAs. , 2013, Molecular cell.

[33]  Nora Engel,et al.  The Kcnq1ot1 Long Non-Coding RNA Affects Chromatin Conformation and Expression of Kcnq1, but Does Not Regulate Its Imprinting in the Developing Heart , 2012, PLoS genetics.

[34]  H. Nagase,et al.  miR‐34a is downregulated in cis‐diamminedichloroplatinum treated sinonasal squamous cell carcinoma patients with poor prognosis , 2012, Cancer science.

[35]  P. Fraser,et al.  No-Nonsense Functions for Long Noncoding RNAs , 2011, Cell.

[36]  Shunsuke Noguchi,et al.  Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells. , 2011, Cancer letters.

[37]  D. Klionsky,et al.  Eaten alive: a history of macroautophagy , 2010, Nature Cell Biology.

[38]  A. Balmain,et al.  Guidelines for the welfare and use of animals in cancer research , 2010, British Journal of Cancer.

[39]  Hiroyuki Kumeta,et al.  The structure of Atg4B–LC3 complex reveals the mechanism of LC3 processing and delipidation during autophagy , 2009, The EMBO journal.

[40]  J. Komorowski,et al.  Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. , 2008, Molecular cell.

[41]  Guido Kroemer,et al.  Self-eating and self-killing: crosstalk between autophagy and apoptosis , 2007, Nature Reviews Molecular Cell Biology.

[42]  L. Kèlland,et al.  The resurgence of platinum-based cancer chemotherapy , 2007, Nature Reviews Cancer.

[43]  T. Mukai,et al.  Imprinting disruption of the CDKN1C/KCNQ1OT1 domain: the molecular mechanisms causing Beckwith-Wiedemann syndrome and cancer , 2006, Cytogenetic and Genome Research.

[44]  F. Inagaki,et al.  Structural Basis for the Specificity and Catalysis of Human Atg4B Responsible for Mammalian Autophagy* , 2005, Journal of Biological Chemistry.

[45]  V. Lelyveld,et al.  A Single Protease, Apg4B, Is Specific for the Autophagy-related Ubiquitin-like Proteins GATE-16, MAP1-LC3, GABARAP, and Apg8L* , 2003, Journal of Biological Chemistry.

[46]  Haiqiu Liao,et al.  Methylation-induced silencing of miR-34a enhances chemoresistance by directly upregulating ATG4B-induced autophagy through AMPK/mTOR pathway in prostate cancer. , 2016, Oncology reports.

[47]  L. Kastl,et al.  miRNA-34a is associated with docetaxel resistance in human breast cancer cells , 2011, Breast Cancer Research and Treatment.

[48]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.